Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN): Powering the Next Generation of Research supports early-career investigators' disrupted projects to sustain neurodegenerative research.
The Investor-Initiated Research Grants from Beyond Batten Disease Foundation fund global research to advance understanding and treatment of juvenile Batten (CLN3) disease.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
2027 Next Generation Research Grants support early-career researchers conducting disease-specific and cross-condition neurological investigations to help launch academic careers in neurological research.
The National Psoriasis Foundation's Bridge Grants provide one year of funding to support ongoing research in psoriatic disease for investigators with strong but unfunded NIH-style proposals.